What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 1 minute read Pharma Industry News Suven Life Sciences to launch phase 3 clinical trial for Masupirdine Suven Life Sciences is set to launch a phase 3 clinical trial for its 5-HT6 antagonist SUVN-502 (Masupirdine)… bySrinathAugust 16, 2021